Literature DB >> 8750977

Changes in expression of NR-1 and c-jun mRNA in rat lumbar spinal cord after neonatal common peroneal nerve crush.

C Hay1, L Virgo, G Mentis, R Navarrete, J de Belleroche.   

Abstract

We have examined the expression of the NR-1 subunit of the glutamate NMDA receptor and the immediate early gene c-jun in lumbar spinal cord following neonatal common peroneal nerve crush. The expression of these two genes was studied up to 12 days post-injury (crush occurring at neonatal day P2). The levels of both NR-1 and c-jun mRNA were increased in spinal cord ipsilateral to the site of crush, the induction of mRNA was shown to occur in a time-dependent manner, peaking at 5 days post-injury. The level of NR-1 mRNA showed the most substantial change following nerve crush, increasing 5 times from 4 h to 5 days post-crush. An increase in expression of NR-1 was also observed in spinal cord contralateral to the injury, although quantitatively this was a smaller effect. These results indicate that early postnatal injury causes a significant increase in the expression of NR-1 mRNA which is most marked at 5 days after injury. This period coincides with that of maximum cell death and indicates that the selective induction of NR-1 could underlie the mechanism of this cell death.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8750977     DOI: 10.1016/0006-8993(95)01286-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  2 in total

1.  Axotomy-induced changes in the properties of NMDA receptor channels in rat spinal cord motoneurons.

Authors:  Galya Abdrachmanova; Jan Teisinger; Ladislav Vyklický
Journal:  J Physiol       Date:  2002-01-01       Impact factor: 5.182

2.  Transcriptional profiling in the lumbar spinal cord of a mouse model of amyotrophic lateral sclerosis: a role for wild-type superoxide dismutase 1 in sporadic disease?

Authors:  Antonello D'Arrigo; Davide Colavito; Emiliano Peña-Altamira; Michele Fabris; Mauro Dam; Antonio Contestabile; Alberta Leon
Journal:  J Mol Neurosci       Date:  2010-02-23       Impact factor: 3.444

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.